US Stock MarketDetailed Quotes

SXTP 60 Degrees Pharmaceuticals

Watchlist
  • 0.225
  • +0.002+0.85%
Close May 17 16:00 ET
  • 0.222
  • -0.003-1.24%
Post 18:46 ET
2.73MMarket Cap-2615P/E (TTM)

60 Degrees Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

60 Degrees Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

116.46K

+578.21%
EPS(YoY)

0.03

+106.43%
Analyst Rating

Buy

Apr 8, 2024

60 Degrees Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 284.000K--
--2024/Q2-- / 223.000K--
--2024/Q1116.460K / 150.000K--
--2023/Q4125.680K / 100.000K--
--2023/Q3126.750K / 100.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 284.000K--
--2024/Q2-- / 223.000K--
--2024/Q1116.460K / 150.000K--
--2023/Q4125.680K / 100.000K--
--2023/Q3126.750K / 100.000K--

60 Degrees Pharmaceuticals Earnings Reports

  • 10-Q: Quarterly report

    May 15 12:00 ET

  • 60 Degrees Pharmaceuticals | 10-K: Annual report

    Apr 1 14:37 ET

  • 60 Degrees Pharmaceuticals: Q3 2023 Earnings Report

    Nov 20, 2023 12:41 ET

  • 60 Degrees Pharmaceuticals | 10-Q: Quarterly report

    Aug 25, 2023 15:26 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Apr 8, 2024

    Buy

    • Buy

      50.00%

    • Hold

      50.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg